An antineoplastic compound which also has antimetabolite action. The drug is used in the therapy of acute leukemia.
For remission induction and remission consolidation treatment of acute nonlymphocytic leukemias.
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
University Malaya Medical Centre, Kuala Lumpur, Malaysia
Subang Jaya Medical Centre, Kuala Lumpur, Malaysia
KK Women's and Children's Hospital, Singapore, Singapore
Princess Maxima Centre for Pediatric Oncology, Utrecht, Netherlands
Unité d'hématologie pédiatrique CHRU de Lille - Hôpital Jeanne de Flandre, Lille, France
UZ Antwerpen Kinderhemato-oncologie, Edegem, Belgium
Henry Ford Health Saint John Hospital, Detroit, Michigan, United States
Michigan State University Clinical Center, East Lansing, Michigan, United States
Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids, Michigan, United States
IWK Health Centre, Halifax, Nova Scotia, Canada
McMaster Children's Hospital at Hamilton Health Sciences, Hamilton, Ontario, Canada
Henry Ford Health Saint John Hospital, Detroit, Michigan, United States
AOUC Policlinico Bari, Bari, Italy
A.O. Papa Giovanni XXIII, Bergamo, Italy
S.O. Annunziata - A. O. Cosenza, Cosenza, Italy
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.